期刊文献+

氟康唑胶囊联合大蒜素注射液治疗慢性乙型重型肝炎合并真菌感染的疗效分析 被引量:8

Analysis of curative effect on treating with fluconazole capsule and galic injection for patients of chronic severe hepatitis B with fungal infections
下载PDF
导出
摘要 目的探讨慢性乙型重型肝炎合并真菌感染时抗真菌治疗的最佳治疗方案。方法将慢性乙型重型肝炎合并真菌感染的患者随机分成4组,每组方案连续治疗7d。治疗组给予每天口服氟康唑胶囊首剂0.4g,以后每次0.2g,每日3次,同时配合大蒜素注射液60mg加入5%葡萄糖500mL中静脉点滴,每日1次。对照1组单用大蒜素注射液60mg加入5%葡萄糖500mL中静脉点滴,每日1次。对照2组单用用氟康唑胶囊首剂0.4g,以后每次0.2g,每日3次。对照3组单用氟康唑注射液100mL(0.2g)静脉点滴,每日1次。结果治疗组在疗效/副作用的综合评价中同对照组相比具有显著的优越性。结论氟康唑联合大蒜素注射液是治疗慢性乙型重型肝炎合并真菌感染的理想治疗方案。 【Objective】 To inquire into the best plan in curing the patients of chronic severe hepatitis B together with fungal infections. 【Methods】 100 patients were divided into 4 groups. The treatment group was used by galic injection (60 mg galic injection+5% Glucose 500 mL iv drip, qd) and fluconazole capsule (0.4 g for the first time, then 0.2 g for each time, 3 times a day); the control group 1 was used by galic injection (60 mg galic injection+5% Glucose 500 mL iv drip qd); the control group 2 was used by fluconazole capsule (0.4 g for the first time, then 0.2 g for each time, 3 times a day); the control group 3 was used by fluconazole injection (0.2 g iv drip, qd). Observe the patients' change of the temperature, the liver level arid side effect. 【Results】 The ratio of the curative effect/side effect in the treatment was higher than the other groups. 【Conclusion】 Fluconazolc capsule and galic injection was ideal therapeutic plan for patients of chronic severe hepatitis B with fungal infections.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第2期276-278,280,共4页 China Journal of Modern Medicine
关键词 氟康唑胶囊 大蒜素注射液 慢性乙型重型肝炎 真菌感染 临床观察 fluconazole capsule galic injection chronic severe hepatitis B fungal infections clinical observation
  • 相关文献

参考文献8

二级参考文献19

  • 1杜斌,张海涛,陈德昌,刘大为,侯百东,熊雯,刘彤华,陈杰.3447例尸检病例的深部真菌感染分析[J].中华医学杂志,1996,76(5):352-354. 被引量:119
  • 2载白英 刘裕昆 汪复.实用抗菌药物学 第2版[M].上海:上海科学技术出版社,1998.252—253.
  • 3Thomas JG, Madigan M.A retrospective study to evaluate a computer based model for amp; ifying, 1 )early anti - fungal intervention and 2) microbial detection of patients at risk for fungemia[ abstract]. Seventh Ammual Focus on Fungal Infections.march, 1997 ,San Amtoioo,TX.
  • 4Uzun O, Ascioglu S, Anaissie El, et al. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia [J ]. Clin Infect Dis,2001,32(12) : 1713 - 1717.
  • 5Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstremn infections in surgical intensive unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey[J]. Clin Infect Dis,2001,33(2) : 177 - 186.
  • 6Pitier D, Monod M, Suter PM, et al. Candida colonization and subsequent infection in critically ill surgical patients[J]. Ann Surg, 1994,220(6) :751 - 758.
  • 7Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A metaanalysis of 16 randomized ,controlled trials[J]. Cancer,2000,89(7):1611 - 1625.
  • 8Kontoyiannis DP, Bodey GP, Mantzoros CS. Fluconazole vs. amphotericin B for the management of candidatmlia in adults: a meta- analysis[J].Mycoses. 2001.44(5) : 125 - 135.
  • 9戴自英,实用抗菌药物学,1992年,252页
  • 10唐整,中华皮肤科杂志,1986年,19卷,6期,335页

共引文献19810

同被引文献92

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部